Related Experiment Video
Updated: Feb 27, 2026
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.5K
DRESS Syndrome: Drug Reaction With Eosinophilia and Systemic Symptoms
1Professor (Corneli), University of Utah School of Medicine, Department of Pediatrics, Division of Pediatric Emergency Medicine, Salt Lake City, UT.
Pediatric Emergency Care
|July 1, 2017
Summary
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a severe, potentially fatal drug reaction. This review aids clinicians in recognizing and differentiating DRESS syndrome, which can be challenging due to its rarity.
Area of Science:
- Dermatology
- Clinical Pharmacology
- Internal Medicine
Background:
- DRESS syndrome is a severe cutaneous and systemic drug reaction.
- It presents with significant morbidity and mortality.
- Delayed recognition can complicate patient management.
Purpose of the Study:
- To provide key elements for recognizing DRESS syndrome.
- To assist clinicians in the differential diagnosis of DRESS syndrome.
- To address the challenges associated with this rare condition.
Main Methods:
- Literature review focusing on DRESS syndrome.
- Analysis of clinical presentation and diagnostic criteria.
- Discussion of differential diagnosis strategies.
Main Results:
- DRESS syndrome requires careful clinical evaluation.
- Characteristic features aid in diagnosis.
- Distinguishing DRESS from other conditions is crucial.
Conclusions:
- Early recognition and accurate diagnosis of DRESS syndrome are vital.
- This review offers practical guidance for clinicians.
- Improved diagnostic skills can mitigate severe complications.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
64
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
64
01:27Allergic Drug Reactions
1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
01:30Toxidromes: Clinical Features
47
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
47
02:06Allergic Reactions
32.7K
Overview
32.7K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
798
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
798
01:30Allergic Reactions: Anaphylaxis
77
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
77